← Back to Clinical Trials
Recruiting NCT07358026

NCT07358026 EARLY-PREG: A Preconception Cohort Study Based on Counterfactuals to Study Maternal-Embryonic Molecular Interactions

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07358026
Status Recruiting
Phase
Sponsor MELISA Institute Genomics & Proteomics Research SpA
Condition Early Pregnancy
Study Type OBSERVATIONAL
Enrollment 223 participants
Start Date 2017-07-11
Primary Completion 2026-12

Trial Parameters

Condition Early Pregnancy
Sponsor MELISA Institute Genomics & Proteomics Research SpA
Study Type OBSERVATIONAL
Phase N/A
Enrollment 223
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2017-07-11
Completion 2026-12
Interventions
EMBRYO EXPOSURE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

EARLY-PREG is an open-cohort clinical study with a preconception, longitudinal, bidirectional and counterfactual design. The aim of this cohort is to investigate the proteomic signatures of maternal-embryonic communication by interrogating a growing biorepository of maternal fluids and tissues collected during the first two weeks after fertilisation. Participants in the EARLY-PREG cohort consist of healthy couples seeking pregnancy, as well as women who are not seeking to conceive. The three main outcomes in the cohort are defined according to menstrual cycles in which conception is achieved and those in which conception is not achieved. Their clinical definitions are as follows: * Pregnancy with a full-term live birth refers to the cycle in which the ovum is fertilised, leading to pregnancy, with beta-hCG levels above the clinical threshold for a positive pregnancy test. * Early pregnancy loss refers to a miscarriage up to 12 6/7 weeks. * Non-pregnancy refers to a menstrual cycle in which conception does not occur, confirmed by a clinically negative beta-hCG test. When referring to the same individual, this is, by definition, considered the counterfactual to the corresponding conception cycle.

Eligibility Criteria

Inclusion criteria: * being between 18 and 40 years of age * not being pregnant * normal colposcopy * body mass index (BMI) between 18 and 29 * regular menstrual cycles (21-35 days) * absence of chronic diseases (hypertension, diabetes mellitus, cancer, depression, personality disorder, thyroid pathology, polycystic ovary syndrome, or hyperprolactinemia). * If seeking pregnancy, they were included if their partners were males between 18 and 40 years old, without pathologies (diabetes mellitus, depression, personality disorder, or cancer), were not taking chronic medication, without erectile disorders, BMI between 18 and 29.9, moderate alcohol use, and with no recreational drug use. Exclusion criteria: * pregnant women * history of alcoholism * infertility treatment * endometriosis * pelvic inflammatory disease * pelvic surgery * allergy to latex or silicone * If seeking pregnancy, they were excluded if their partners were working in contact with pesticides, or with history of erectile

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology